California Jury Says J&J (JNJ) Defectively Designed ASR Hip Device
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq hit record highs as Treasury yields stall, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Johnson & Johnson (JNJ) Hip Implant Verdict to be Readt at 12:30pm ET
March 8, 2013 12:23 PM ESTJohnson & Johnson (NYSE: JNJ) hip implant jury verdict to be read at 9:30am in Los Angeles (PST), or 12:30pm EST.
Johnson & Johnson was accused of selling a defective hip implant.
Shares are up 0.4 percent Friday.... More



